Revvity
Myriam Guerbaa is a seasoned professional in the fields of NGS and genomics, currently serving as the NGS & Genomics Market Development Leader and Regional Sales Manager for France at Revvity since May 2023. With extensive experience at PerkinElmer, Inc. from 2013 to 2023 as a Regional Sales Manager and Segment Leader in Genomics for EMEA, Guerbaa specialized in molecular diagnostic products, including advanced technologies for cytogenetics and oncology. Previous roles at Fresenius Kabi and various internships focused on genetics and biotechnology research further established a strong foundation in life sciences. Myriam Guerbaa holds a Master's degree in Genetics, Biotechnology, and Microbiology from Edinburgh Napier University, complemented by additional postgraduate studies in biotech commercialization and molecular cell biology from leading French universities.
This person is not in any teams
This person is not in any offices
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com